Immunogenic Cell Death Inducing Fluorinated Mitochondria‐Disrupting Helical Polypeptide Synergizes with PD‐L1 Immune Checkpoint Blockade-Reference-Cited by-同舟云学术

Immunogenic Cell Death Inducing Fluorinated Mitochondria‐Disrupting Helical Polypeptide Synergizes with PD‐L1 Immune Checkpoint Blockade

Published:2021-02 Issue:7 Volume:8 Page:2001308
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Adv. Sci.

Author:

Jeong Seong Dong¹,Jung Bo‐Kyeong²^ORCID,Ahn Hyo Min²³,Lee DaeYong¹,Ha JongHoon¹,Noh Ilkoo¹,Yun Chae‐Ok²³⁴^ORCID,Kim Yeu‐Chun¹^ORCID

Affiliation:

1. Department of Chemical and Biomolecular Engineering Korea Advanced Institute of Science and Technology (KAIST) Daejeon 34141 Republic of Korea

2. Department of Bioengineering, College of Engineering Hanyang University Seoul 04763 Republic of Korea

3. GeneMedicine Co., Ltd. Seoul 04763 Republic of Korea

4. Institute of Nano Science and Technology (INST) Hanyang University Seoul 04763 Republic of Korea

Funder

National Research Foundation of Korea

National Research Foundation

Korea Drug Development Fund

Ministry of Trade, Industry and Energy

Ministry of Health and Welfare

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202001308

Reference38 articles.

1. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

2. Antitumor Activity in Melanoma and Anti-Self Responses in a Phase I Trial With the Anti-Cytotoxic T Lymphocyte–Associated Antigen 4 Monoclonal Antibody CP-675,206

3. Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1

4. Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

5. Immune checkpoint inhibitors: recent progress and potential biomarkers

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Berberine sensitizes immune checkpoint blockade therapy in melanoma by NQO1 inhibition and ROS activation;International Immunopharmacology;2024-12

2. Chimeric peptide-engineered immunostimulant for endoplasmic reticulum targeted photodynamic immunotherapy against metastatic tumor;Journal of Controlled Release;2024-10

3. Rationally designed catalytic nanoplatform for enhanced chemoimmunotherapy via deploying endogenous plus exogenous copper and remodeling tumor microenvironment;Journal of Nanobiotechnology;2024-09-09

4. Tumor phagocytosis-driven STING activation invigorates antitumor immunity and reprograms the tumor micro-environment;Journal of Controlled Release;2024-09

5. Strategies to enhance the therapeutic efficacy of anti-PD-1 antibody, anti-PD-L1 antibody and anti-CTLA-4 antibody in cancer therapy;Journal of Translational Medicine;2024-08-09